& Serrano, M.
Cellular senescence: from physiology to pathology. Nat. Rev.
Mol. Cell Biol.
15, 482–496 (2014)
Pérez-Mancera, P. A.,
Young, A. R. &
Inside and out: the activities of senescence in cancer. Nat.
14, 547–558 (2014)
Zon, L. I.
Intrinsic and extrinsic control of haematopoietic stem-cell
453, 306–313 (2008)
et al. Implications of cellular senescence in tissue damage
response, tumor suppression, and stem cell biology. Cold Spring
Harb. Symp. Quant. Biol.
73, 513–522 (2008)
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. &
Lowe, S. W.
Oncogenic ras provokes premature cell senescence associated with
accumulation of p53 and p16INK4a. Cell
88, 593–602 (1997)
et al. Oncogene-induced senescence as an initial barrier in lymphoma
436, 660–665 (2005)
et al. BRAFE600-associated senescence-like cell cycle
arrest of human naevi. Nature
436, 720–724 (2005)
Schmitt, C. A. et al. A
senescence program controlled by p53 and p16INK4a contributes
to the outcome of cancer therapy. Cell
109, 335–346 (2002)
Dörr, J. R.
et al. Synthetic lethal metabolic targeting of cellular senescence
in cancer therapy. Nature
501, 421–425 (2013)
Onder, T. T.
et al. Chromatin-modifying enzymes as modulators of
483, 598–602 (2012)
Krizhanovsky, V. &
Lowe, S. W.
Stem cells: The promises and perils of p53. Nature
460, 1085–1086 (2009)
et al. Regulation of chromatin structure by site-specific histone H3
406, 593–599 (2000)
et al. Rb-mediated heterochromatin formation and silencing of E2F
target genes during cellular senescence. Cell
113, 703–716 (2003)
et al. H3K9 methylation is a barrier during somatic cell
reprogramming into iPSCs. Nat. Genet.
45, 34–42 (2013)
et al. Tissue damage and senescence provide critical signals for
cellular reprogramming in vivo. Science
354, aaf4445 (2016)
et al. The senescence-associated secretory phenotype induces
cellular plasticity and tissue regeneration. Genes Dev.
31, 172–183 (2017)
Wong, D. J.
et al. Module map of stem cell genes guides creation of epithelial
cancer stem cells. Cell Stem Cell
2, 333–344 (2008)
et al. A role for Wnt signalling in self-renewal of haematopoietic
stem cells. Nature
423, 409–414 (2003)
et al. The Wnt/beta-catenin pathway is required for the development
of leukemia stem cells in AML. Science
327, 1650–1653 (2010)
Lin, A. W. et al. Premature
senescence involving p53 and p16 is activated in response to constitutive
MEK/MAPK mitogenic signaling. Genes Dev.
12, 3008–3019 (1998)
Kelly, P. N., Dakic, A., Adams, J. M., Nutt, S. L. &
Tumor growth need not be driven by rare cancer stem cells.
317, 337 (2007)
Chaffer, C. L.
et al. Normal and neoplastic nonstem cells can spontaneously convert
to a stem-like state. Proc. Natl Acad. Sci. USA
108, 7950–7955 (2011)
Zhao, Z. et al. p53 loss
promotes acute myeloid leukemia by enabling aberrant self-renewal.
24, 1389–1402 (2010)
et al. RNAi screen identifies Brd4 as a therapeutic target in acute
myeloid leukaemia. Nature
478, 524–528 (2011)
Acosta, J. C.
et al. A complex secretory program orchestrated by the inflammasome
controls paracrine senescence. Nat. Cell Biol.
15, 978–990 (2013)
Baker, D. J.
et al. Naturally occurring p16Ink4a-positive cells
shorten healthy lifespan. Nature
530, 184–189 (2016)
Baar, M. P.
et al. Targeted apoptosis of senescent cells restores tissue
homeostasis in response to chemotoxicity and aging. Cell
169, 132–147.e16 (2017)
Pawlikowski, J. S.
et al. Wnt signaling potentiates nevogenesis. Proc. Natl
Acad. Sci. USA
110, 16009–16014 (2013)
Haugstetter, A. M.
et al. Cellular senescence predicts treatment outcome in
metastasised colorectal cancer. Br. J. Cancer
103, 505–509 (2010)
Adams, J. M.
et al. The c-myc oncogene driven by immunoglobulin enhancers
induces lymphoid malignancy in transgenic mice. Nature
318, 533–538 (1985)
Peters, A. H.
et al. Loss of the Suv39h histone methyltransferases impairs
mammalian heterochromatin and genome stability. Cell
107, 323–337 (2001)
Martins, C. P.,
Brown-Swigart, L. &
Evan, G. I.
Modeling the therapeutic efficacy of p53 restoration in tumors.
127, 1323–1334 (2006)
et al. Tumor stroma-derived TGF-β limits myc-driven
lymphomagenesis via Suv39h1-dependent senescence. Cancer
17, 262–272 (2010)
Schmitt, C. A. et al.
Dissecting p53 tumor suppressor functions in vivo.
1, 289–298 (2002)
Premsrirut, P. K.
et al. A rapid and scalable system for studying gene function in
mice using conditional RNA interference. Cell
145, 145–158 (2011)
Schmitt, C. A.,
McCurrach, M. E., de Stanchina, E.,
Wallace-Brodeur, R. R. &
Lowe, S. W.
INK4a/ARF mutations accelerate lymphomagenesis and
promote chemoresistance by disabling p53. Genes Dev.
13, 2670–2677 (1999)
Banchereau, J., de Paoli, P., Vallé, A., Garcia, E.
& Rousset, F.
Long-term human B cell lines dependent on interleukin-4 and antibody to
251, 70–72 (1991)
Schmitt, C. A.,
Rosenthal, C. T. &
Lowe, S. W.
Genetic analysis of chemoresistance in primary murine lymphomas.
6, 1029–1035 (2000)
Feil, R., Wagner, J., Metzger, D.
& Chambon, P.
Regulation of Cre recombinase activity by mutated estrogen receptor
ligand-binding domains. Biochem. Biophys. Res. Commun.
237, 752–757 (1997)
et al. Opposing roles of NF-κB in anti-cancer treatment
outcome unveiled by cross-species investigations. Genes
25, 2137–2146 (2011)
Yang, D. H.
et al. Wnt5a is required for endothelial differentiation of
embryonic stem cells and vascularization via pathways involving both
Wnt/β-catenin and protein kinase Cα.
104, 372–379 (2009)
Dickins, R. A.
et al. Probing tumor phenotypes using stable and regulated synthetic
microRNA precursors. Nat. Genet.
37, 1289–1295 (2005)
Godar, S. et al.
Growth-inhibitory and tumor- suppressive functions of p53 depend on its
repression of CD44 expression. Cell
134, 62–73 (2008)
Dimri, G. P.
et al. A biomarker that identifies senescent human cells in culture
and in aging skin in vivo. Proc. Natl Acad. Sci. USA
92, 9363–9367 (1995)
et al. The Myc-evoked DNA damage response accounts for treatment
resistance in primary lymphomas in vivo. Blood
110, 2996–3004 (2007)
Greve, B., Kelsch, R., Spaniol, K.,
Eich, H. T. &
Flow cytometry in cancer stem cell analysis and separation.
81A, 284–293 (2012)
Gupta, P. B.
et al. Identification of selective inhibitors of cancer stem cells
by high-throughput screening. Cell
138, 645–659 (2009)
et al. Salinomycin inhibits Wnt signaling and selectively induces
apoptosis in chronic lymphocytic leukemia cells. Proc. Natl Acad.
108, 13253–13257 (2011)
et al. A Myc network accounts for similarities between embryonic
stem and cancer cell transcription programs. Cell
143, 313–324 (2010)
et al. Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc. Natl Acad.
102, 15545–15550 (2005)
Rappsilber, J., Mann, M. & Ishihama, Y.
Protocol for micro-purification, enrichment, pre-fractionation and storage
of peptides for proteomics using StageTips. Nat. Protocols
2, 1896–1906 (2007)
Boersema, P. J.,
Mohammed, S. &
Heck, A. J.
Multiplex peptide stable isotope dimethyl labeling for quantitative
proteomics. Nat. Protocols
4, 484–494 (2009)
Cox, J. &
MaxQuant enables high peptide identification rates, individualized
p.p.b.-range mass accuracies and proteome-wide protein quantification.
26, 1367–1372 (2008)
Lee, T. I.,
Johnstone, S. E. &
Young, R. A.
Chromatin immunoprecipitation and microarray-based analysis of protein
location. Nat. Protocols
1, 729–748 (2006)
Hu, Y. &
Smyth, G. K.
ELDA: extreme limiting dilution analysis for comparing depleted and
enriched populations in stem cell and other assays. J. Immunol.
347, 70–78 (2009)
Ivanova, N. B.
et al. A stem cell molecular signature. Science
298, 601–604 (2002)
Coppé, J. P.,
Desprez, P. Y.,
Krtolica, A. &
The senescence-associated secretory phenotype: the dark side of tumor
suppression. Annu. Rev. Pathol.
5, 99–118 (2010)
Whitfield, M. L.
et al. Identification of genes periodically expressed in the human
cell cycle and their expression in tumors. Mol. Biol. Cell
13, 1977–2000 (2002)
et al. The molecular portraits of breast tumors are conserved across
microarray platforms. BMC Genomics
7, 96 (2006)
Chambers, S. M.
et al. Hematopoietic fingerprints: an expression database of stem
cells and their progeny. Cell Stem Cell
1, 578–591 (2007)